User profiles for Maja Relja
 | Maja Reljadr. sc., dr. med., profesor neurologije Verified email at mef.hr Cited by 3171 |
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease
Background A Task Force was convened by the EFNS / MDS ‐ ES Scientist Panel on P
arkinson's disease ( PD ) and other movement disorders to systemically review relevant …
arkinson's disease ( PD ) and other movement disorders to systemically review relevant …
Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: A cross-sectional …
Background Animal data and postmortem studies suggest a role of oxidative stress in the
Huntington's disease (HD), but in vivo human studies have been scarce. Aim To assess the …
Huntington's disease (HD), but in vivo human studies have been scarce. Aim To assess the …
Is quality of life in non‐demented Parkinson's disease patients related to cognitive performance? A clinic‐based cross‐sectional study
Whilst the association between dementia and poorer health‐related quality of life (Hr‐QoL)
in Parkinson’s disease (PD) has been well established, we aimed to explore the relationship …
in Parkinson’s disease (PD) has been well established, we aimed to explore the relationship …
A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of …
Our aim was to evaluate the safety and efficacy of botulinum toxin type A (BoNTA; BOTOX ®
) for prophylaxis of episodic migraine. In this double-blind, placebo-controlled study, patients …
) for prophylaxis of episodic migraine. In this double-blind, placebo-controlled study, patients …
Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in
pain and functional disability. Local injections of botulinum neurotoxin are currently the …
pain and functional disability. Local injections of botulinum neurotoxin are currently the …
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
Cervical dystonia is a neurological movement disorder causing abnormal posture of the head.
It may be accompanied by involuntary movements which are sometimes tremulous. The …
It may be accompanied by involuntary movements which are sometimes tremulous. The …
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy
…, F Micheli, O Orlova, S Paus, Z Pirtosek, M Relja… - Journal of …, 2018 - Springer
Spasticity is a symptom occurring in many neurological conditions including stroke, multiple
sclerosis, hypoxic brain damage, traumatic brain injury, tumours and heredodegenerative …
sclerosis, hypoxic brain damage, traumatic brain injury, tumours and heredodegenerative …
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by
treatment algorithms and injection schemes describing its target muscles and their dosing. …
treatment algorithms and injection schemes describing its target muscles and their dosing. …
Botulinum toxin type A in experimental neuropathic pain
… Hence, according to open-label and some double-blind studies, BTX-A treatment was
found to be effective in chronic tension-type headaches (Relja and Telarovic, 2004; Schulte-Mattler …
found to be effective in chronic tension-type headaches (Relja and Telarovic, 2004; Schulte-Mattler …
Update on the management of Parkinson's disease for general neurologists
Management of Parkinson’s disease (PD) is complicated due to its progressive nature, the
individual patient heterogeneity, and the wide range of signs, symptoms, and daily activities …
individual patient heterogeneity, and the wide range of signs, symptoms, and daily activities …
